Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients

Alfredo E. Echeverria, Matthew McCurdy, Richard Castillo, Vincent Bernard, Natalia Velez Ramos, William Buckley, Edward Castillo, Ping Liu, Josue Martinez, Thomas Guerrero

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Purpose: This study quantifies pulmonary radiation toxicity in patients who received proton therapy for esophagus cancer. Materials/methods: We retrospectively studied 100 esophagus cancer patients treated with proton therapy. The linearity of the enhanced FDG uptake vs. proton dose was evaluated using the Akaike Information Criterion (AIC). Pneumonitis symptoms (RP) were assessed using the Common Toxicity Criteria for Adverse Events version 4.0 (CTCAEv4). The interaction of the imaging response with dosimetric parameters and symptoms was evaluated. Results: The RP scores were: 0 grade 4/5, 7 grade 3, 20 grade 2, 37 grade 1, and 36 grade 0. Each dosimetric parameter was significantly higher for the symptomatic group. The AIC winning models were 30 linear, 52 linear quadratic, and 18 linear logarithmic. There was no significant difference in the linear coefficient between models. The slope of the FDG vs. proton dose response was 0.022 for the symptomatic and 0.012 for the asymptomatic (p = 0.014). Combining dosimetric parameters with the slope did not improve the sensitivity or accuracy in identifying symptomatic cases. Conclusions: The proton radiation dose response on FDG PET/CT imaging exhibited a predominantly linear dose response on modeling. Symptomatic patients had a higher dose response slope.

Original languageEnglish (US)
Pages (from-to)124-129
Number of pages6
JournalRadiotherapy and Oncology
Volume106
Issue number1
DOIs
StatePublished - Jan 2013
Externally publishedYes

Fingerprint

Proton Therapy
Radiation Pneumonitis
Esophageal Neoplasms
Protons
Radiation
Pneumonia
Lung

Keywords

  • Positron emission tomography
  • Proton therapy
  • Radiation pneumonitis

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Hematology

Cite this

Echeverria, A. E., McCurdy, M., Castillo, R., Bernard, V., Ramos, N. V., Buckley, W., ... Guerrero, T. (2013). Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients. Radiotherapy and Oncology, 106(1), 124-129. https://doi.org/10.1016/j.radonc.2012.09.003

Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients. / Echeverria, Alfredo E.; McCurdy, Matthew; Castillo, Richard; Bernard, Vincent; Ramos, Natalia Velez; Buckley, William; Castillo, Edward; Liu, Ping; Martinez, Josue; Guerrero, Thomas.

In: Radiotherapy and Oncology, Vol. 106, No. 1, 01.2013, p. 124-129.

Research output: Contribution to journalArticle

Echeverria, AE, McCurdy, M, Castillo, R, Bernard, V, Ramos, NV, Buckley, W, Castillo, E, Liu, P, Martinez, J & Guerrero, T 2013, 'Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients', Radiotherapy and Oncology, vol. 106, no. 1, pp. 124-129. https://doi.org/10.1016/j.radonc.2012.09.003
Echeverria AE, McCurdy M, Castillo R, Bernard V, Ramos NV, Buckley W et al. Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients. Radiotherapy and Oncology. 2013 Jan;106(1):124-129. https://doi.org/10.1016/j.radonc.2012.09.003
Echeverria, Alfredo E. ; McCurdy, Matthew ; Castillo, Richard ; Bernard, Vincent ; Ramos, Natalia Velez ; Buckley, William ; Castillo, Edward ; Liu, Ping ; Martinez, Josue ; Guerrero, Thomas. / Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients. In: Radiotherapy and Oncology. 2013 ; Vol. 106, No. 1. pp. 124-129.
@article{5f03a3ebe4f34ca7be4961fa5d597025,
title = "Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients",
abstract = "Purpose: This study quantifies pulmonary radiation toxicity in patients who received proton therapy for esophagus cancer. Materials/methods: We retrospectively studied 100 esophagus cancer patients treated with proton therapy. The linearity of the enhanced FDG uptake vs. proton dose was evaluated using the Akaike Information Criterion (AIC). Pneumonitis symptoms (RP) were assessed using the Common Toxicity Criteria for Adverse Events version 4.0 (CTCAEv4). The interaction of the imaging response with dosimetric parameters and symptoms was evaluated. Results: The RP scores were: 0 grade 4/5, 7 grade 3, 20 grade 2, 37 grade 1, and 36 grade 0. Each dosimetric parameter was significantly higher for the symptomatic group. The AIC winning models were 30 linear, 52 linear quadratic, and 18 linear logarithmic. There was no significant difference in the linear coefficient between models. The slope of the FDG vs. proton dose response was 0.022 for the symptomatic and 0.012 for the asymptomatic (p = 0.014). Combining dosimetric parameters with the slope did not improve the sensitivity or accuracy in identifying symptomatic cases. Conclusions: The proton radiation dose response on FDG PET/CT imaging exhibited a predominantly linear dose response on modeling. Symptomatic patients had a higher dose response slope.",
keywords = "Positron emission tomography, Proton therapy, Radiation pneumonitis",
author = "Echeverria, {Alfredo E.} and Matthew McCurdy and Richard Castillo and Vincent Bernard and Ramos, {Natalia Velez} and William Buckley and Edward Castillo and Ping Liu and Josue Martinez and Thomas Guerrero",
year = "2013",
month = "1",
doi = "10.1016/j.radonc.2012.09.003",
language = "English (US)",
volume = "106",
pages = "124--129",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Proton therapy radiation pneumonitis local dose-response in esophagus cancer patients

AU - Echeverria, Alfredo E.

AU - McCurdy, Matthew

AU - Castillo, Richard

AU - Bernard, Vincent

AU - Ramos, Natalia Velez

AU - Buckley, William

AU - Castillo, Edward

AU - Liu, Ping

AU - Martinez, Josue

AU - Guerrero, Thomas

PY - 2013/1

Y1 - 2013/1

N2 - Purpose: This study quantifies pulmonary radiation toxicity in patients who received proton therapy for esophagus cancer. Materials/methods: We retrospectively studied 100 esophagus cancer patients treated with proton therapy. The linearity of the enhanced FDG uptake vs. proton dose was evaluated using the Akaike Information Criterion (AIC). Pneumonitis symptoms (RP) were assessed using the Common Toxicity Criteria for Adverse Events version 4.0 (CTCAEv4). The interaction of the imaging response with dosimetric parameters and symptoms was evaluated. Results: The RP scores were: 0 grade 4/5, 7 grade 3, 20 grade 2, 37 grade 1, and 36 grade 0. Each dosimetric parameter was significantly higher for the symptomatic group. The AIC winning models were 30 linear, 52 linear quadratic, and 18 linear logarithmic. There was no significant difference in the linear coefficient between models. The slope of the FDG vs. proton dose response was 0.022 for the symptomatic and 0.012 for the asymptomatic (p = 0.014). Combining dosimetric parameters with the slope did not improve the sensitivity or accuracy in identifying symptomatic cases. Conclusions: The proton radiation dose response on FDG PET/CT imaging exhibited a predominantly linear dose response on modeling. Symptomatic patients had a higher dose response slope.

AB - Purpose: This study quantifies pulmonary radiation toxicity in patients who received proton therapy for esophagus cancer. Materials/methods: We retrospectively studied 100 esophagus cancer patients treated with proton therapy. The linearity of the enhanced FDG uptake vs. proton dose was evaluated using the Akaike Information Criterion (AIC). Pneumonitis symptoms (RP) were assessed using the Common Toxicity Criteria for Adverse Events version 4.0 (CTCAEv4). The interaction of the imaging response with dosimetric parameters and symptoms was evaluated. Results: The RP scores were: 0 grade 4/5, 7 grade 3, 20 grade 2, 37 grade 1, and 36 grade 0. Each dosimetric parameter was significantly higher for the symptomatic group. The AIC winning models were 30 linear, 52 linear quadratic, and 18 linear logarithmic. There was no significant difference in the linear coefficient between models. The slope of the FDG vs. proton dose response was 0.022 for the symptomatic and 0.012 for the asymptomatic (p = 0.014). Combining dosimetric parameters with the slope did not improve the sensitivity or accuracy in identifying symptomatic cases. Conclusions: The proton radiation dose response on FDG PET/CT imaging exhibited a predominantly linear dose response on modeling. Symptomatic patients had a higher dose response slope.

KW - Positron emission tomography

KW - Proton therapy

KW - Radiation pneumonitis

UR - http://www.scopus.com/inward/record.url?scp=84874660870&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84874660870&partnerID=8YFLogxK

U2 - 10.1016/j.radonc.2012.09.003

DO - 10.1016/j.radonc.2012.09.003

M3 - Article

C2 - 23127772

AN - SCOPUS:84874660870

VL - 106

SP - 124

EP - 129

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

IS - 1

ER -